Corporate Governance18 Jul 2026, 08:40 pm
AstraZeneca Pharma India Files Revised BRSR Report
AI Summary
AstraZeneca Pharma India Ltd has submitted a revised intimation regarding its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. The revision was necessitated by the inadvertent omission of certain pages from the assurance statement in the previous filing. The company has enclosed the revised BRSR along with the Independent Practitioner's Limited Assurance Report from KPMG Assurance and Consulting Services LLP, which forms part of the Annual Report. The report details the company's commitment to sustainability, focusing on how it makes a sustainable impact through science and innovation, and how it conducts its business ethically and responsibly.
Key Highlights
- Revised Business Responsibility and Sustainability Report filed.
- KPMG provided limited assurance on BRSR Core Indicators.
- Report covers FY 2025-26, focusing on sustainability impact.
- Company emphasizes science, innovation, and ethical business practices.
Price Impact
More from ASTRAZEN